The global Antimicrobial Susceptibility Testing Market is estimated to be valued at US$ 3751.4 Mn in 2023 and is expected to exhibit a CAGR of 6.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
Antimicrobial susceptibility testing helps in determining which particular antimicrobials like antibiotics, antifungals, antivirals or antiseptics will work best to treat an infection by matching the identified or suspected pathogen to the antimicrobial agents that are most likely to work. It provides useful information for clinicians to decide on appropriate drug and dosage regimen for treating infections in their patients.

Market Dynamics:
The growth of the antimicrobial susceptibility testing market is attributed to the rising prevalence of infectious diseases worldwide. According to the World Health Organization, infectious diseases account for around 26% of all global deaths. Rapid increase in antibiotic resistance pathogens and lack of new effective antibiotics in development pipeline are also fueling the demand for AST to optimize antibiotic usage. Furthermore, advancement in AST technologies such as molecular diagnostics and automated systems provide accurate test results in lesser time, thus driving their adoption. Stringent regulations regarding periodic surveillance of antibiotic resistance in healthcare setups across major countries further supports the market growth.

SWOT Analysis
Strength: Antimicrobial Susceptibility Testing helps determine the most effective antibiotic treatments for infections. It helps avoid antibiotic overuse and resistance. Automated AST systems provide accurate and quick results in 24-48 hours to guide appropriate antibiotic therapy. These next-generation platforms have added advantages of antimicrobial susceptibility profiling and detailed reporting.
Weakness: High costs of automated AST platforms can limit their adoption in resource-constrained settings. Manual AST methods are time-consuming and require experienced laboratory technicians. Interpretation of results also requires skilled medical professionals.
Opportunity: Rising bacterial antimicrobial resistance globally has increased the clinical need for AST to optimize antibiotic usage. This along with recent innovations in automated platforms will support market growth. Increased funding and policy focus on AMR also promotes increased AST capacity building.
Threats: Lack of standardization and differences in testing methods, breakpoints and reporting can affect accurate monitoring of resistance trends. Insufficient diagnostic infrastructure in low and middle-income nations limits widespread access to AST.

Key Takeaways
The global Antimicrobial Susceptibility Testing Market Demand is expected to witness high growth, exhibiting CAGR of 6.4% over the forecast period, due to increasing microbial drug resistance and optimal antibiotic usage.

Regional analysis
North America dominates the market currently due to widespread adoption of automated systems in clinical microbiology labs. Asia Pacific is expected to grow at the fastest rate due to rising healthcare investment, infections, and initiatives to strengthen AMR containment.

Key players
Key players operating in the Antimicrobial Susceptibility Testing market are HiMedia Laboratories, Alifax S.r.l. Italy, Creative Diagnostics, Resistell AG, Danaher, Becton, Dickinson and Company, Merck KGaA, Bio-Rad Laboratories, Inc., Bruker, Nissui Pharmaceutical Co., Ltd., F. Hoffmann-La Roche Ltd.,Synbiosis, Mast Group Ltd., ELITechGroup, Flinn Scientific, CONDALAB, Accelerate Diagnostics, Inc. and Zhuhai DL Biotech Co., Ltd.

For More Details On The Report,  Read- https://blogger-veritas.blogspot.com/2023/12/antimicrobial-susceptibility-testing.html